×
About 1,483 results

ALLMedicine™ Chronic Gastritis Center

Research & Reviews  495 results

Biochemical characterization, and anti-inflammatory and antitumor activities of glycopr...
https://doi.org/10.1016/j.jep.2023.116359
Journal of Ethnopharmacology; Arken A, Zhao X et. al.

Mar 26th, 2023 - Lamb abomasum is used as an edible medicinal source in traditional Chinese medicine for the treatment of gastrointestinal disorders. Lamb abomasum sourced biochemical drug Lamb's trip extract and Vitamin B12 capsule used for the clinical treatment...

Impact of Helicobacter pylori on the gastric microbiome in patients with chronic gastri...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10030478
BMJ Open; Cao X, Yang Y et. al.

Mar 18th, 2023 - Chronic gastritis is a common disease worldwide. Studies have consistently shown that chronic gastritis is usually associated with gastric microbial dysbiosis, especially the infection of Helicobacter pylori. However, the interaction between H. py...

Relationship between Helicobacter pylori virulence genes and gastroduodenal disease.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026102
The Journal of International Medical Research; Wattanawongdon W, Simawaranon Bartpho T et. al.

Mar 17th, 2023 - This study aimed to identify Helicobacter pylori virulence factors and examine their associations with clinical outcomes in Thai patients. Moreover, the association between these genotypes and gastric mucosa morphological patterns was investigated...

The Anti-Helicobacter pylori effects of Limosilactobacillus reuteri strain 2892 isolate...
https://doi.org/10.1007/s11274-023-03555-x
World Journal of Microbiology & Biotechnology; Forooghi Nia F, Rahmati A et. al.

Mar 16th, 2023 - Helicobacter pylori infection (H. pylori) is associated with chronic gastritis, peptic ulcers, and gastric cancer. The present study provides information on the protective effects of Limosilactobacillus reuteri strain 2892 (L. reuteri 2892) isolat...

Protective Effects of Cudrania tricuspidata Against Helicobacter pylori-Induced Inflamm...
https://doi.org/10.1089/jmf.2022.K.0133
Journal of Medicinal Food; Lee JY, Son HG et. al.

Mar 3rd, 2023 - Helicobacter pylori modulates the host inflammatory response, resulting in chronic gastritis, which contributes to gastric cancer pathogenesis. We verified the effect of Cudrania tricuspidata on H. pylori infection by inhibiting H. pylori-induced ...

see more →

Guidelines  1 results

British Society of Gastroenterology guidelines on the diagnosis and management of patie...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709778
Gut Banks M, Graham D et. al.

Jul 7th, 2019 - Gastric adenocarcinoma carries a poor prognosis, in part due to the late stage of diagnosis. Risk factors include Helicobacter pylori infection, family history of gastric cancer-in particular, hereditary diffuse gastric cancer and pernicious anaem...

see more →

Drugs  2 results see all →

Clinicaltrials.gov  70 results

European Registry on the Management of Helicobacter Pylori Infection
https://clinicaltrials.gov/ct2/show/NCT02328131

Mar 1st, 2023 - Abstract Introduction: H. pylori selectively infects the human stomach mucosa, being the most prevalent chronic infection in the world. Its prevalence correlates with socioeconomic factors and it is higher in older individuals. H. pylori presence ...

Assessment of the Role of Incisura Biopsy in the Staging of Chronic Gastritis
https://clinicaltrials.gov/ct2/show/NCT05744596

Feb 27th, 2023 - This prospective multicenter study investigates the added benefit of incisura biopsy to correct identification of patients with high-risk chronic gastritis (OLGA stages III-IV). It compares a biopsy protocol with and without a single incisura biop...

The Study About the Selection of Time for Retreatment of Helicobacter Pylori After Eradication Failure
https://clinicaltrials.gov/ct2/show/NCT05173493

Feb 17th, 2023 - Helicobacter pylori (HP) infection is a common global infectious disease, which is an important cause of chronic gastritis, peptic ulcer and gastric cancer. At present, due to the non-standard Helicobacter pylori eradication program in clinical wo...

Efficacies of HDDT With or Without Bismuth vs Amoxicillin-metronidazole BQT for First-line H Pylori Eradication
https://clinicaltrials.gov/ct2/show/NCT03897244

Feb 17th, 2023 - This prospective multicenter randomized comparative study will be conducted at the National Taiwan University Hospital(NTUH), NTUH Bei-Hu Branch, NTUH Hsin-Chu Branch, Buddhist Tzu Chi General Hospital, and Mennonite Christian Hospital in Hua-Lien...

One vs Two Weeks Treatment for H.Pylori Eradication A RANDOMIZED NON-INFERIORITY PLACEBO CONTROLLED TRIAL
https://clinicaltrials.gov/ct2/show/NCT05728424

Feb 15th, 2023 - Introduction: The overall aim of the study is to assess the efficacy of one week of Vonoprazan compared to two weeks of Vonoprazan in eradicating H-Pylori in patients with dyspeptic symptoms. H. pylori is a pathogenic Gram-negative spiral bacillus...

see more →

News  18 results

Fast Five Quiz: Helicobacter pylori
https://reference.medscape.com/viewarticle/950663

Jan 20th, 2022 - Helicobacter pylori is a gram-negative microaerophilic bacterium that infects the lining of the stomach. It is the chief cause of chronic gastritis and the primary etiological agent for gastric cancer and peptic ulcer disease (PUD). Despite effort...

Pink plaque on the ear
https://www.mdedge.com/familymedicine/article/237252/dermatology/pink-plaque-ear
MDedge Family Medicine;

Mar 25th, 2021 - A 4-mm punch biopsy was performed and revealed B-cell lymphoma, consistent with extranodal marginal zone lymphoma. The plaque was palpated carefully and the location of branches of the superficial temporal artery, which usually course anterior to.

Chronic Gastritis, a Lesion, and Weight Loss in a Teenager
https://reference.medscape.com/viewarticle/843821

Feb 19th, 2021 - Editor's Note: The Case Challenge series includes difficult-to-diagnose conditions, some of which are not frequently encountered by most clinicians but are nonetheless important to accurately recognize. Test your diagnostic and treatment skills us...

Expert Highlights Assay to Determine Patients With Lung, Gastrointestinal Cancers to Receive Pembrolizumab
https://www.onclive.com/view/expert-highlights-assay-to-determine-patients-with-lung--gastrointestinal-cancers-to-receive-pembrolizumab-

Dec 4th, 2020 - Lawrence M. Weiss, MD The PD-L1 immunohistochemistry (IHC) 22C3 pharmDx can be an aid in identifying patients with non—small cell lung cancer (NSCLC) and gastrointestinal cancers who are eligible for pembrolizumab (Keytruda) monotherapy, accordin...

H. Pylori Tx Cuts Gastric Cancer Risk Long Term
https://www.medpagetoday.com/gastroenterology/pepticulcerdisease/89849

Nov 23rd, 2020 - Helicobacter pylori (H. pylori) therapy and eradication protected against progression to gastric cancer in Hispanic patients with pre-cancerous lesions, and the protective effect of therapy endured at 20 years, researchers reported. In the longest...

see more →

Patient Education  7 results see all →